| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/09/2005 | WO2005051919A1 Aminopyrazole derivatives as gsk-3 inhibitors |
| 06/09/2005 | WO2005051913A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | WO2005051911A1 4-phenylpiperidine derivatives as renin inhibitors |
| 06/09/2005 | WO2005051879A1 Process for producing epoxytriazole compound and intermediate therefor |
| 06/09/2005 | WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/09/2005 | WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 06/09/2005 | WO2005051382A1 Agent enhancing lipid-loewring effect |
| 06/09/2005 | WO2005051381A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) |
| 06/09/2005 | WO2005051380A1 Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r) |
| 06/09/2005 | WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/09/2005 | WO2005016893A3 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 06/09/2005 | WO2003088897A3 Fab i inhibitors |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124677 Peptide deformylase inhibitors |
| 06/09/2005 | US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124664 Compounds for treatment of cardiovascular disorders using inhibitors of plasmnogen activator as anticoagulants for blood |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 06/09/2005 | US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/09/2005 | US20050124638 Benzimidazoles and analogs thereof as antivirals |
| 06/09/2005 | US20050124634 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 06/09/2005 | US20050124633 For the treatment of myosin heavy chain-mediated diseases, and in particular, heart failure |
| 06/09/2005 | US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders |
| 06/09/2005 | US20050124619 Medical devices employing triazine compounds and compositions thereof |
| 06/09/2005 | US20050124614 E. g., 3,5-bis-trifluoromethylphenyl)-4-[(furan-2-ylmethyl)-aminocarbonyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline;anticarcinogenic agents; antitumor agents; antiproliferative agents; activators of the caspase cascades; enzyme inhibitors used in combination with radiation or chemotherapy |
| 06/09/2005 | US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 06/09/2005 | US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 06/09/2005 | US20050124599 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050124532 Using nucleoside, or prodrug thereof |
| 06/09/2005 | US20050124209 Illuminated electrical cords and outlets |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | CA2547472A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 06/09/2005 | CA2546264A1 4-phenylpiperidine derivatives as renin inhibitors |
| 06/09/2005 | CA2545601A1 Quinazolinone compounds with reduced bioaccumulation |
| 06/09/2005 | CA2545262A1 Quinazoline derivatives |
| 06/09/2005 | CA2544857A1 Vitamin d receptor modulators |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537103A1 Antidepressant cycloalkylamine derivates of 2,3-dihydro-1,4-benzodioxan |
| 06/08/2005 | EP1537102A1 Inhibition of phsphoinostide 3-dinase beta |
| 06/08/2005 | EP1537100A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 06/08/2005 | EP1537099A1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 06/08/2005 | EP1537085A1 Oxytocin inhibitors |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1537081A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 06/08/2005 | EP1537078A1 Indoles having anti-diabetic activity |
| 06/08/2005 | EP1536799A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 06/08/2005 | EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 06/08/2005 | EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1370528B1 Mch antagonists and their use in the treatment of obesity |
| 06/08/2005 | EP1268306A4 Inverted aerosol dispenser |
| 06/08/2005 | EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 06/08/2005 | EP0922029B1 Ether muscarinic antagonists |
| 06/08/2005 | CN1625559A Novel compounds that inhibit factor Xa activity |
| 06/08/2005 | CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/08/2005 | CN1625550A Process for the manufacture of organic compounds |
| 06/08/2005 | CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative |
| 06/08/2005 | CN1625400A 2, 4-pyrimidinediamine compounds and their uses |
| 06/08/2005 | CN1623984A Fused-ring compounds and use thereof as drugs |
| 06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
| 06/08/2005 | CN1205245C Epoxy resins, process for production thereof, epoxy resin compositions and crured articles |
| 06/08/2005 | CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof |
| 06/08/2005 | CN1205198C Cyclic ketone derivative and pharmaceutical use thereof |
| 06/08/2005 | CN1205187C New amidino derivatives and their use as thrombin inhibitors |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903224 Substituted with purine or pyrimidine bases |
| 06/07/2005 | US6903219 Process to produce derivatives from UK-2A derivatives |
| 06/07/2005 | US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903212 Reacting cyanuric acid with epichlorohydrin to form an addition product; removing epichlorohydrin; dissolving the triglycidyl isocyanurate in a solvent; gradually cooling at a rate within 20 degrees C./hr followed by filtration |
| 06/07/2005 | US6903180 Epoxy resins, process for preparation thereof, epoxy resin compositions and cured articles |
| 06/07/2005 | US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903123 Antitussive agents, anxiolytic agents, analgesics for treating cough, anxiety and pain |
| 06/07/2005 | US6903120 Modulators of dopamine neurotransmission |
| 06/07/2005 | US6903116 For therapy and prophylaxis of cancer and stress diseases such as depression |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903109 Arylindenopyridines and related therapeutic and prophylactic methods |
| 06/07/2005 | US6903105 Nitrogen compounds such as 4-(4-(N-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)guanidino)butyl)-N-(2 -aminoethyl)benzamide hydrochloride, administered for prophylaxis of respiratory system disorders; pharmocokinetics |
| 06/07/2005 | US6903103 Linear cyclic ureas |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903097 Heterocycle carboxamides as antiviral agents |
| 06/07/2005 | US6903095 Phthalimido derivatives and a process for their preparation |
| 06/07/2005 | US6903094 As analgesic |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | US6902936 Analyzing protein mixturea, obtain protein mixture, in cubate withblocking agent, digent protein, reduce disulfides, incubate with thiol specific substrates, detect and measure signal from sample |
| 06/07/2005 | CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives |
| 06/02/2005 | WO2005049610A1 Process for preparing thiazolidinediones |
| 06/02/2005 | WO2005049608A1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| 06/02/2005 | WO2005049604A2 Antithrombotic aromatic ethers |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |